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A cytotoxin-like basic protein (CLBP) was isolated from the venom of the Thailand cobra (Naja naja sia- 
mensis). The cytotoxicity ofCLBP toward FL cells was one order of magnitude lower than those of cytotox- 
ins. The amino acid sequence was determined by a combination ofconventional methods. The total number 
of amino acid residues was 62, giving a molecular mass of 6977 Da. The sequence at residues 25-30 in the 
CLBP molecule was found to be significantly different from those of cytotoxins. This region might play 
an important role in the cytotoxic activity of cytotoxins. 
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1. INTRODUCTION 
Cobra venom cytotoxins (cardiotoxins) are 
highly basic polypeptides consisting of 60-61 
amino acid residues, and exhibit cytotoxic ac- 
tivities against many kinds of cells such as Yoshida 
sarcoma cells and Fogh-Lund (FL) cells. Recently, 
a cardiotoxin-like basic polypeptide (CLBP) and a 
less cytotoxic basic polypeptide (LCBP) were 
isolated from the venoms of the Formosan cobra 
(Naja naja atra) [1] and the Indian cobra (N. naja) 
[2], respectively. These proteins had amino acid se- 
quences similar to those of cytotoxins although 
their cytotoxic activities were much lower than 
those of cytotoxins. Here, we isolated a cytotoxin- 
like basic protein, designated CLBP, from the 
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venom of the Thailand cobra (N. naja siamensis), 
determined the amino acid sequence, and com- 
pared the sequence with those of cytotoxins. 
2. MATERIALS AND METHODS 
2.1. Isolation of  toxins from cobra venom 
The lyophilized venom of N. naja siamensis was 
obtained from Miami Serpentarium (USA). Toxins 
were separated by gel filtration on Sephadex G-75 
followed by CM-cellulose column chromatography 
as described [3]. 1 9 venom was dissolved in 1 o70 
acetic acid and applied to a Sephadex G-75 column 
equilibrated with the same solvent. The fraction 
containing proteins of about 5-10 kDa was 
lyophilized and subjected to CM-cellulose column 
chromatography, the column having been 
equilibrated with 0.1 M sodium acetate (pH 6.0). 
Toxins were eluted with a linear gradient from 0.1 
M sodium acetate (pH 6.0) to 0.5 M sodium 
acetate buffer (pH 6.5). Each fraction obtained 
was desalted on a Sephadex G-25 column and 
lyophilized. The homogeneity was confirmed by 
reversed-phase HPLC on a SynChropak RP-8 col- 
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umn (SynChrom, USA) with 0.1°70 tr i f luoroacet ic 
acid containing a l inear gradient f rom 0 to 45°7o 
acetonitri le. S-carboxymethylated (Cm) derivatives 
of  cytotoxin and cytotoxin- l ike basic protein were 
prepared by the method o f  Crestf ield et al. [4]. 
Fig.1. CM-cellulose column chromatography of the 
fraction obtained from Sephadex G-75 column 
chromatography. A CM-cellulose column (2.7 x 90 cm) 
was equilibrated with 0.1 M sodium acetate buffer (pH 
6.0) and the toxins were eluted by a linear gradient from 
solution A, 0.1 M sodium acetate buffer (pH 6.0), to 
solution B, 0.5 M sodium acetate buffer (pH 6.5). 
Fractions of 13 ml each were collected at a flow rate of 
62 ml/h. 
2.2. Cytotoxicity toward FL cells 
FL  cells were suspended in phosphate-buf fered 
saline (PBS) at a concentrat ion of  2 .5x106 
cel ls/ml.  Various concentrat ions o f  each protein 
fract ion were added separately to the cell suspen- 
sions and the mixtures were incubated at 37°C for 
30 min. The cytotoxic activity was measured by the 
Amino acid compositions and cytotoxicities 
Table 1 
of the fractions obtained 
in fig. 1 
from the CM-cellulose chromatography shown 
Amino acid P-1 P-2 P-3 P-4 P-5 P-6 P-7-1 P-7-2 P-7-3 P-8 
Cys n.d.(10) n.d. n.d. n.d. 7.6 n.d. 8.2 8.4 8.5 7.8 (8) 
Asp 9.0 (9) 7.9 8.1 8.0 7.8 5.2 7.4 7.9 6.0 7.1 (7) 
Thr 8.6 (9) 10.0 6.1 7.4 2.9 2.8 2.3 2.9 3.0 4.0 (4) 
Ser 2.9 (3) 2.9 3.6 3.5 2.8 1.8 1.2 1.8 1.7 2.0 (2) 
Glu 1.1 (1) 8.1 6.3 7.1 0.1 5.7 0.1 0.0 0.8 2.2 (2) 
Pro 6.4 (6) 2.7 3.1 2.1 4.1 3.8 5.3 4.3 4.8 4.8 (5) 
Gly 4.1 (4) 7.4 5.1 6.9 2.1 4.0 2.2 2.1 2.2 2.3 (2) 
Ala 3.2 (3) 0.4 0.7 0.1 2.0 1.1 4.9 2 .8  1.8 3.0 (3) 
Val 3.5 (4) 1.4 2.0 1.1 3.7 1.1 4.7 5.0 5.5 1.3 (1) 
Met 0.0 (0) 0.0 0.1 0.0 2.6 2.0 2.0 2.0 1.7 0.0 (0) 
lie 4.6 (5) 0.5 1.9 2.0 3.8 3.9 1.9 1.9 1.3 2.8 (3) 
Leu 1.0 (1) 2.1 2.2 1.1 6.0 4.3 6.3 6.2 5.7 6.8 (7) 
Tyr 1.0 (1) 2.1 1.2 2.0 1.3 2.1 2.9 3.1 2.9 1.9 (2) 
Phe 3.0 (3) 0.4 0.3 0.1 1.0 3.1 1.1 1.1 1.9 2.9 (3) 
Lys 4.7 (5) 3.5 5.4 2.2 7.6 4.8 9.0 8.5 8.3 10.6(11) 
His 0.9 (1) 2.0 1.9 1.9 0.2 1.0 0.2 0.1 0.3 1.1 (1) 
Arg 4.8 (5) 6.3 4.2 6.9 2.0 6.5 2.2 2.0 2.5 1.2 (1) 
Trp n.d. (1) n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. (0) 
Total 71 . . . . . . . .  62 
50°7o cytotoxicity (/zg/ml) > 100 
Toxins NT 
> 100 > 100 > 100 5.4 > 100 10.6 16.1 12.6 > 100 
NT NT NT CT-I NT CT-II CT-III CT-IV CLBP 
The values in parentheses of fractions P-1 and P-8 were based on the amino acid sequence cited from [9] and that deter- 
mined in this study, respectively. Cysteine was determined as carboxymethylcysteine, n.d., not determined; NT, neuro- 
toxin; CT, cytotoxin; CLBP, cytotoxin-like basic protein 
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trypan-blue xclusion test as in [5|. Cytotoxicity 
was expressed as EDs0: the protein concentration 
required to cause lysis of 50°7o f the cells. 
2.3. Amino acid analysis 
The protein and peptide samples were hydro- 
lyzed with 6 N HCI containing 0.2°70 phenol at 
l l0°C for 24 h in evacuated sealed tubes. The 
amino acid compositions were determined with an 
amino acid analyzer (Hitachi model L-8500). 
2.4. Studies on the amino acid sequence of CLBP 
1 mg Cm-CLBP was digested in 0.1 M 
NH4HCO3 overnight at 40°C with 20 /zg 
staphylococcal protease (Miles Scientific, USA) or 
TPCK-trypsin (Sigma, USA). The peptides thus 
obtained were separated by reversed-phase HPLC 
on a Cosmosil 5C18-300 column (Nakarai, Japan) 
with 0.1 °70 trifluoroacetic acid containing a linear 
gradient from 0 to 70% acetonitrile. The manual 
Edman degradation method was used to determine 
the N-terminal sequences of Cm-CLBP and pep- 
tides. PTH-amino acids were generally identified 
by HPLC [6], and in some cases by TLC [7]. The 
C-terminal sequence of Cm-CLBP was determined 
by carboxypeptidase digestion [8]: the protein sam- 
pie was digested by carboxypeptidase A (Sigma) at 
40°C for 120 min in 0.1 M Tris-HCl buffer (pH 
8.0) and the amino acids released were determined 
with the amino acid analyzer. 
3. RESULTS 
3.1. Isolation of toxins from Thailand cobra 
venom 
Fig. 1 shows the CM-cellulose column chromato- 
graphic profile of the protein fraction obtained 
from Sephadex G-75 column chromatography of
the N. naja siamensis venom. As judged from the 
results of reversed-phase HPLC, fractions P1-P-6 
and P-8 were homogeneous, but this was not the 
case for fraction P-7. The latter fraction was found 
to be composed of three subfractions (P-7-1, 
P-7-2, P-7-3) that had peaks at fraction nos 434, 
445 and 465, respectively. Table 1 shows the amino 
acid compositions and the cytotoxicities toward FL 
ceils of all these protein fractions. The amino acid 
composition of fraction P-1 agreed with that of the 
long neurotoxin already sequenced [9]. Fractions 
P-2, P-3, P-4 and P-6 were assigned to the short 
neurotoxin or its homologues, since their amino 
acid compositions were very similar to those of the 
short neurotoxins [10], whereas fractions P-5, 
P-7-1, P-7-2 and P-7-3 were assigned to the cyto- 
toxins, since they showed high cytotoxic activities. 
These cytotoxins were designated as cytotoxin I
(CT-I), II (CT-II), III (CT-III), and IV (CT-IV), 
respectively. Sequence studies on these cytotoxins 
are now in progress. Fraction P-8 showed low 
cytotoxic activity, though its amino acid composi- 
tion was similar to those of the cytotoxins. Similar 
cytotoxin-like basic proteins (CLBP) had been 
already isolated from the venoms of the Formosan 
cobra (N. naja atra) [1] and the Indian cobra (N. 
naja) [2]. 
3.2. Amino acid sequence of cytotoxin-like basic 
protein 
Fraction P-8 was S-carboxymethylated, and the 
N-terminal sequence of this Cm-CLBP was deter- 
mined to be the following: H-Leu-Lys-Cmc-His- 
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Fig.2. Separation of the staphylococcal protease digest 
of Cm-CLBP. The digest was fractionated by HPLC as 
described in seetion 2. 
19 
Volume 218, number 1 FEBS LETTERS June 1987 
Table 2 
Amino acid compositions of staphylococcal protease peptides (S-I, S-2) and tryptic peptides (T-I-T-9) of Cm-CLBP 
Amino acid S-I S-2 T-1 T-2 T-3 T-4 T-5 T-6 T-7 T-8 T-9 
Cmc 2.18(2) 6.45(6) 
Asp 1.18(1) 5.91(6) 
Thr 1.77(2) 2.16(2) 
Ser 0.15 1.77(2) 
Glu 1.86(2) 0.30 
Pro 2.00(2) 3.34(3) 
Gly 0.12 1.92(2) 
Ala 0.12 2.88(3) 
Val 0.19 1.15(1) 
Met 
lie 0.91(1) 1.95(2) 
Leu 1.97(2) 5.00(5) 
Tyr 0.93(1) 1.05(1) 
Phe 0.95(1) 2.01(2) 
Lys 2.15(2) 9.14(9) 
His 0.88(1) 0.15 
Arg 1.07(1) 
Total 17 45 
Yield (°70) 25.5 19.8 
0.75(1) 0.92(1) 1.06(1) 1.99(2) 2.81(3) 
0.79(1) 0.85(1) 1.02(1) 1.93(2) 1.04(1) 1.78(2) 
0.81(1) 0.93(1) 0.12 0.96(1) 
0.13 0.81(1) 0.81(1) 
0.75(1) 0.95(1) 
1.01(1) 0.87(1) 1.72(2) 0.85(1) 
0.98(1) 0.14 0.99(1) 
0.99(1) 0.96(1) 0.96(1) 
0.89(1) 
0.83(1) 1.78(2) 
1.01(1) 1.35(1) 0.98(1) 0.97(1) 1.11(1) 1.96(2) 
0.71(1) 0.95(1) 
0.93(1) 0.99(1) 1.05(1) 
0.99(1) 0.73(1) 1.06(1) 1.01(1) 1.03(1) 2.83(3) 1.09(1) 1.02(1) 1.11(1) 
0.62(1) 
0.10 0.89(1) 
2 11 6 5 4 10 8 6 10 
35.0 9.7 ,34.8 41.6 26.1 25.5 13.5 45.2 19.9 
Values in parentheses were taken from the sequence 
Asn-Thr-Gln-Leu-Pro-Phe-Ile-Tyr-Lys-Thr-Cmc- 
Pro-Glu-Gly-Lys-Asn-Leu-Cmc-Phe-Lys-Ala-Thr- 
Leu-Lys-Lys-Phe-Pro-Leu-. Carboxypeptidase A 
released asparagine (0.7 mol/mol protein) and car- 
boxymethylcysteine (0.16 mol/mol protein) after a 
120 min incubation, suggesting the C-terminal 
residues of Cm-CLBP to be -Cmc-Asn-COOH. 
The staphylococcal protease digest of Cm-CLBP 
was subjected to HPLC (fig.2). The amino acid 
compositions of the two separated peptides, S-1 
and S-2, are shown in table 2. The C-terminal frag- 
ment, S-2, was subjected to manual Edman 
degradation. The tryptic digest of Cm-CLBP was 
separated by HPLC into nine fragments, T-l-T-9, 
and their amino acid compositions were determin- 
ed (table 2). The sequence studies on Cm-CLBP 
described above are summarized in fig.3. The total 
number of amino acid residues was 62, giving a 
molecular mass of 6977 Da. 
When the amino acid sequence of CLBP was 
compared with those of cytotoxins, remarkable 
amino acid replacements were observed at residues 
25-30, where hydrophobic amino acid residues in 
cytotoxins were replaced by hydrophilic ones in 
CLBP. This region might play an important role in 
the cytotoxic activity of cytotoxins. 
The determined sequence of CLBP of N. naja 
siamensis differed from those of CLBP of N. naja 
atra [1] and LCBP of N. naja [2] in nine amino 
acid residues: the residues at 25, 26, 27, 28, 29, 30, 
31, 34 and 36. The sequence Ala-Thr-Leu-Lys at 
positions 25-28 of the N. naja siamensis CLBP 
1 10 20 
Leu-Lys••ys•His-As•-Thr-G1n-Leu-Pr•-Phe-n•-Tyr-Lys-Thr=Cys-Pr•-G1u-G1y-Ly•-As•-L•u- 
~T- I~ I T-2" -T-3 I 
30 40 
Cy s-Pha-Ly s-^ Is-Thr -Leu-Lys-Ly a-Phe-Pr o-Leu-Lys- I le-Pr o-I le-Ly s-Ar g~l  y-Cya-Ala-Asp- 
--T-~ 7 _~T-~ *L_~7 ~ "T-6 II T -7 - -  
50 60 ~--- ~- -  
Asn-Cys-Pro-Lys-Asn-Ser-Ala-Leu-Leu-Lys-Tyr-Val-Cys-Cys-Ser-Thr-Asp-Lys-Cys-Asn 
q 
~ -9 i 
Fig.3. Summary of the sequence studies on CLBP. S- 
and T- refer to the staphylococcal protease peptides and 
tryptic peptides, respectively. The amino acid sequence 
was determined by the manual Edman degradation (~) 
and carboxypeptidase digestion (~) methods. Cys was 
determined as Cm-cysteine. 
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was found at positions 29-32 in the sequence of 
CLBP from N. naja atra and LCBP from N. naja. 
This difference probably arose from the misalign- 
ment of the tryptic peptides obtained from the lat- 
ter two proteins. Reinvestigation of the sequences 
of CLBP from N. naja atra and LCBP from N. na- 
ja is now in progress. 
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